Skip to content

Sanara MedTech Inc. SMTI Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$107.51M+4.2%$103.14M+1.2%$101.9M+4.8%$97.24M+6.2%$91.57M+5.7%
$7.61M+1.2%$7.52M-4.7%$7.9M-1.5%$8.01M-0.9%$8.08M-0.7%
$99.9M+4.5%$95.62M+1.7%$94.01M+5.4%$89.23M+6.9%$83.49M+6.3%
92.9%+0.2pp92.7%+0.5pp92.3%+0.5pp91.8%+0.6pp91.2%+0.6pp
$5.08M-3.6%$5.27M+28.0%$4.12M+6.3%$3.88M+7.5%$3.6M+0.1%
$83.39M+3.4%$80.64M-0.2%$80.78M+3.1%$78.32M+3.4%$75.73M+4.0%
$93.29M+2.7%$90.84M+3.2%$88.01M+3.1%$85.4M+3.5%$82.51M+3.2%
$6.61M+38.1%$4.79M-20.2%$6M+56.4%$3.83M+291%$979.63K+171%
6.1%+1.5pp4.6%-1.2pp5.9%+1.9pp3.9%+2.9pp1.1%+2.7pp
$7.24M+7.1%$6.76M+8.8%$6.22M+16.7%$5.33M+27.5%$4.18M+33.6%
-$8.5M-10.4%-$7.7M-12.1%-$6.87M-20.1%-$5.72M-30.7%-$4.38M-36.9%
-$33.58M+10.6%-$37.56M-0.2%-$37.49M-277%-$9.94M+13.0%-$11.43M-18.2%
-31.2%+5.2pp-36.4%+0.4pp-36.8%-26.6pp-10.2%+2.3pp-12.5%-1.3pp
-$3.90+10.6%-$4.36-3.3%-$4.22-264%-$1.16+13.4%-$1.34-17.5%
$10.02M+14.7%$8.73M-19.8%$10.88M+23.9%$8.78M+48.3%$5.92M+67.0%
9.3%+0.9pp8.5%-2.2pp10.7%+1.6pp9%+2.6pp6.5%+2.4pp
$6.61M+38.1%$4.79M-20.2%$6M+56.4%$3.83M+291%$979.63K+171%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Sanara MedTech Inc.'s revenue?
Sanara MedTech Inc. (SMTI) generated $107.5M in revenue over the trailing twelve months, up 17.4% year over year.
Is Sanara MedTech Inc. profitable?
Sanara MedTech Inc. is not currently profitable: it reported a net loss of $33.6M over the trailing twelve months, a -31.2% net margin.
What are Sanara MedTech Inc.'s profit margins?
Gross margin is 92.9% and operating margin is 6.1%, with a -31.2% net margin.
What is Sanara MedTech Inc.'s earnings per share?
Sanara MedTech Inc.'s diluted EPS over the trailing twelve months is $-3.90.
Where does Sanara MedTech Inc.'s income statement data come from?
Every line is extracted from Sanara MedTech Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.